Rise and shine, eveyone, another busy day is on the way. And you know what that means - meetings and deadlines and phone calls! Oh my! Of course, there is an elixir for such moments - a delicious cup of stimulation. We are back to Pumpkin Spice this morning, but please join us with whatever potion tickles your fancy. Meanwhile, we have gathered a list of tidbits to help you conquer the midweek hump. Hope your day goes well and do stay in touch if you run across anything intriguing...
AbbVie CFO Sees No Need For Major Acquisitions (Reuters)
FDA Grants First Breakthrough Therapy Designations (Pharma Times)
FDA Inspects Another Massachusetts Compounder (Boston Globe)
Bayer Has No Plan To Sell Diabetes Unit (Bloomberg News)
Amgen And Bind Sign $180M Nanomedicine Deal (Associated Press)
Teva Says Layoffs Will Be Small Part Of Reorg (Philadelphia Inquirer)
Shire Buys Lotus Tissue And Rare Skin Disorder Drug (Boson Business Journal)
Greece Unable To Pay Bills And HIV Meds Are Dwindling (Bloomberg News)
SFDA Says WHO Should Buy More Chinese-Made Drugs (InPharma Technologist)
Biocon Gets India Approval For Novel Psoriasis Drug (Wall Street Journal)
On Eve Of J&J Hip Implant Trial, Plaintiff Pulls Case (Bloomberg News)
EDITOR'S NOTE: Please check this post for updates
steaming coffee pic thx to dleggett on flickr